Angiolab, Inc. Stock

A251280

KR7251280004

Food Processing

End-of-day quote Korea S.E. 13/11/2026			5-day change	1st Jan Change
1,994.00 ^KRW	+7.78%		-8.53%	-18.94%

30/11/21	Angiolab, Inc. announced that it has received KRW 5.499987 billion in funding from Smart CKD Bio-Healthcare No.1 Venture Investment Association, New Wave No. 6 Investment Association, Sori Asset Co., Ltd.	CI
17/11/21	Angiolab, Inc. announced that it expects to receive KRW 5.499987 billion in funding from Smart CKD Bio-Healthcare No.1 Venture Investment Association, New Wave No. 6 Investment Association, Sori Asset Co., Ltd.	CI

AngioLab Inc is a Korea-based company principally engaged in the manufacture and sale of pharmaceuticals. The Company manufactures and sells finished health functional food products using lemon balm extract mixed powder as the main ingredient, and health functional food raw materials such as lemon balm extract mixed powder. In addition, the Company develops pharmaceutical products and health functional foods based on angiogenesis inhibition.

Employees

Sector

Food Processing

More about the company

Quotes

Date	Price	Change	Volume
13/11/26	KRW 1,994.00	+7.78%	41
12/11/26	KRW 1,850.00	-14.55%	2,134
11/11/26	KRW 2,165.00	+0.46%	38
10/11/26	KRW 2,155.00	-0.23%	0
09/11/26	KRW 2,160.00	-0.92%	433

End-of-day quote Korea S.E.

More quotes

Stock Market
Stocks
A251280 Stock

30/11/21	Angiolab, Inc. announced that it has received KRW 5.499987 billion in funding from Smart CKD Bio-Healthcare No.1 Venture Investment Association, New Wave No. 6 Investment Association, Sori Asset Co., Ltd.	CI
17/11/21	Angiolab, Inc. announced that it expects to receive KRW 5.499987 billion in funding from Smart CKD Bio-Healthcare No.1 Venture Investment Association, New Wave No. 6 Investment Association, Sori Asset Co., Ltd.	CI
24/09/20	Hanyang Securities Co., Ltd., Investment Arm and Sun-Tae Kim acquired 2.9% stake in Angiolab, Inc. from KB 12-1 Venture Fund of KB Investment Co., Ltd. for KRW 1.2 billion.	CI
18/09/20	Angiolab, Inc. cancelled the acquisition of NH Special Purpose Acquisition 13 Co., Ltd. from BNK Venture Investment and others in a reverse merger transaction.	CI
29/06/20	Angiolab, Inc. signed a contract to acquire NH Special Purpose Acquisition 13 Co., Ltd. from BNK Venture Investment and others in a reverse merger transaction for KRW 66.3 billion.	CI
19/07/19	Angiolab, Inc. announced that it has received KRW 2.999988 billion in funding from Dt& Investment Co.,Ltd.	CI
28/06/19	Angiolab, Inc. announced that it expects to receive KRW 2.999988 billion in funding from Dt& Investment Co.,Ltd. and another investor	CI
16/04/18	Angiolab, Inc. announced that it has received KRW 646.1616 million in funding from Yuanta Venture Capital Corp.	CI
08/10/14	Angiolab, Inc. announced that it has received KRW 1 billion in funding from Yuanta venture capital.	CI

1 day	+7.78%
1 week	-8.53%
Current month	-8.74%
1 month	-27.49%
3 months	-6.16%
6 months	+4.95%
Current year	-18.94%

1 week	1,845	2,200
1 month	1,845	2,995
Current year	1,523	3,545
1 year	1,523	4,300
3 years	1,523	9,200
5 years	1,523	11,050
10 years	1,523	25,800

Manager	Title	Age	Since
Min-Yeong Kim CEO	Chief Executive Officer	69	03/06/1999
Il-Hwan Jo PRN	Corporate Officer/Principal	65	-
Byeong-Yeong Park CTO	Chief Tech/Sci/R&D Officer	57	27/07/2016

Director	Title	Age	Since
Min-Yeong Kim BRD	Director/Board Member	69	03/06/1999
Byeong-Yeong Park BRD	Director/Board Member	57	27/07/2016
Il-Hwan Jo BRD	Director/Board Member	65	-

Angiolab, Inc. Stock

Stocks

A251280

KR7251280004

Food Processing

Chart: Angiolab, Inc.

Latest news: Angiolab, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Angiolab, Inc.

Special Foods & Wellbeing Products

Financials

Company Profile

Quotes

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ANGIOLAB, INC.	+7.78%	-8.53%	-53.63%	-72.27%	5.21M
NESTLÉ S.A.	+1.33%	+2.18%	+9.23%	-11.75%	269B
MONDELEZ INTERNATIONAL, INC.	+1.47%	+2.30%	+18.78%	-3.65%	85.49B
DANONE	+1.31%	+3.99%	-11.13%	+20.10%	49.55B
GRUPO NUTRESA S. A.	0.00%	0.00%	+21.67%	+566.67%	43.24B
THE HERSHEY COMPANY	+0.57%	-2.14%	-2.75%	-11.91%	35.02B
ARCHER-DANIELS-MIDLAND COMPANY	+2.72%	+4.19%	+24.38%	-1.30%	34.69B
INNER MONGOLIA YILI INDUSTRIAL GROUP CO., LTD.	+2.39%	+0.92%	+11.96%	+16.39%	30.08B
FOSHAN HAITIAN FLAVOURING AND FOOD COMPANY LTD.	+0.61%	-2.49%	-9.19%	-9.02%	29.8B
KRAFT HEINZ	+2.57%	+2.03%	+1.05%	-25.22%	29.73B
Average	+2.08%	+0.29%	+1.04%	+46.80%	61B
Weighted average by Cap.	+1.37%	+1.49%	+8.80%	+34.66%

	2014	2015
Net sales	878M 1,174B 796M 736M 664M 1.25B 82.83B 1.3B 8.84B 3.51B 44.24B 3.3B 3.23B 140B	703M 939B 637M 589M 531M 1B 66.25B 1.04B 7.07B 2.81B 35.39B 2.64B 2.58B 112B
Net income	-350M -468B -317M -294M -265M -499M -33.03B -517M -3.53B -1.4B -17.64B -1.31B -1.29B -56.01B	-1.19B -1,586B -1.08B -995M -897M -1.69B -112B -1.75B -11.95B -4.74B -59.76B -4.45B -4.36B -190B
Net Debt	-	-